The U.S. government has terminated grants funding work it considers to address “DEI,” conflating health equity research with efforts to change the composition and climate of the scientific workforce.
A 65-year-old man presented with a 4-month history of a rash and a 2-month history of diarrhea and weight loss. Examination showed a maculopapular eruption. CT revealed osteosclerosis of thoracic ...
Even with the most reticent patients, Dr. Kolhouse somehow uncovered the things that mattered most to them, discovering each one’s unique definition of a good day — and offering them more of those.
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and ...
Tobacco use kills more than 7 million people worldwide each year, including 1.3 million who die from the effects of exposure to secondhand smoke.1 As a major contributor to cancer, cardiovascular ...
Michael Welsh, Jesús González, and Paul Negulescu have won the 2025 Lasker–DeBakey Clinical Medical Research Award for their roles in developing treatments for cystic fibrosis.
There is an urgent need for low- and middle-income countries to ensure equitable, affordable, and sustained access to tobacco-cessation medications at scale.
In 2019, seven county correctional facilities (jails) in Massachusetts initiated pilot programs to provide all Food and Drug Administration–approved medications for opioid use disorder (MOUD). This ...
A 37-year-old woman presented to the emergency department with a 4-day history of acute pain, swelling, and bruising on the upper portion of the left knee after using an electronic massage gun. Her ...
To the Editor: The BROADWAY trial by Nicholls and colleagues (July 3 issue) 1 was a pivotal evaluation of an intriguing agent. However, I am concerned about the use of placebo in patients with ...
A majority of U.S. Republicans support withholding federal funding from “ultraliberal” universities — but maintaining medical research funding. A national campaign could boost advocacy for such a c ...
We conducted an open-label, randomized trial in Spain and Italy to evaluate the effect of beta-blocker therapy, as compared with no beta-blocker therapy, in patients with acute myocardial infarction ...